← Eichor
Condition: Anti N Methyl D Aspartate Receptor Encephalitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Anti N Methyl D Aspartate Receptor Encephalitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease
Phase 2 · 1 location(s) · Arialys Australia Pty Ltd · NCT07093333Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis
Phase 2 · 1 location(s) · Beijing Tongren Hospital · NCT06510283Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Phase N/A · 13 location(s) · University of Bern · NCT05017142Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
Phase 3 · 2 location(s) · The First People's Hospital of Changzhou · NCT06867991The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Phase 2 · 39 location(s) · University of Utah · NCT04372615
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.